Glukos Med Na40 + K20 Braun

Glukos Med Na40 + K20 Braun is an intravenous injection solution that combines potassium chloride, sodium chloride, and glucose monohydrate. Formulated for parenteral use, it delivers essential electrolytes and carbohydrate energy directly into the bloodstream. The product is manufactured for the EU market and is available by prescription only. It is intended to correct electrolyte disturbances, support fluid balance, and provide rapid glucose supplementation when needed.

Glukos Med Na40 + K20 Braun is indicated for several clinical situations that require rapid electrolyte and fluid replacement. It is commonly employed in hospital settings for patients who need intravenous support.

- Treatment of hypokalemia (low potassium levels) - Management of hyponatremia (low sodium levels) - Peri‑operative fluid and electrolyte replacement during surgery - Replenishment of fluid loss after trauma or extensive burns - Correction of hypoglycemia when oral intake is not possible - Support of intravascular volume in patients with dehydration

Side effects may occur with any intravenous electrolyte solution. Most are mild and transient, but serious reactions are possible and require immediate medical attention.

Common: - Mild irritation or pain at the injection site - Transient nausea or vomiting - Temporary headache - Mild increase in blood pressure - Mild hyperglycemia (elevated blood glucose) - Slight electrolyte imbalance if administered rapidly

Serious: - Severe hyperkalemia leading to cardiac arrhythmia - Acute hypernatremia causing neurological symptoms - Anaphylactic or severe allergic reaction - Phlebitis or thrombophlebitis at the infusion site - Rapid fluid overload resulting in pulmonary edema

Glukos Med Na40 + K20 Braun should be used with careful clinical monitoring to avoid complications. Specific considerations include:

- Verify patient electrolyte levels before and during therapy - Adjust infusion rate in patients with renal impairment or heart failure - Use caution in pregnant or breastfeeding individuals; data are limited - Avoid rapid bolus administration to reduce risk of hyperkalemia - Monitor blood glucose closely in diabetic patients - Ensure proper aseptic technique to prevent infection at the infusion site

Concurrent medications can influence the safety and effectiveness of Glukos Med Na40 + K20 Braun. Interactions fall into two categories:

Avoid: - Potassium-sparing diuretics (e.g., spironolactone) that may cause dangerous hyperkalemia - ACE inhibitors or ARBs combined with high potassium intake - Sodium bicarbonate solutions administered simultaneously, which can cause precipitation

Use with caution: - Other intravenous electrolytes or fluids that may alter sodium/potassium balance - Insulin therapy, which can shift potassium into cells - Beta‑adrenergic agonists that affect serum potassium levels - Anticoagulants, as rapid infusion may affect coagulation parameters